Your search returned 2 results.

Results
	1.	Phase II trial of Belagenpumatucel-L, a TGF-beta2 antisense gene modified allogeneic tumor vaccine in advanced non small cell lung cancer (NSCLC) patients. [electronic resource] by Nemunaitis, J Nemunaitis, M Senzer, N Snitz, P Bedell, C Kumar, P Pappen, B Maples, P B Shawler, D Fakhrai, H Producer: 20090922 In: Cancer gene therapy vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Proof concept for clinical justification of network mapping for personalized cancer therapeutics. [electronic resource] by Nemunaitis, J Senzer, N Khalil, I Shen, Y Kumar, P Tong, A Kuhn, J Lamont, J Nemunaitis, M Rao, D Zhang, Y-A Zhou, Y Vorhies, J Maples, P Hill, C Shanahan, D Producer: 20070919 In: Cancer gene therapy vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search